Cargando…
Targeting SREBP-2-Regulated Mevalonate Metabolism for Cancer Therapy
Recently, targeting metabolic reprogramming has emerged as a potential therapeutic approach for fighting cancer. Sterol regulatory element binding protein-2 (SREBP-2), a basic helix-loop-helix leucine zipper transcription factor, mainly regulates genes involved in cholesterol biosynthesis and homeos...
Autores principales: | Xue, Linyuan, Qi, Hongyu, Zhang, He, Ding, Lu, Huang, Qingxia, Zhao, Daqing, Wu, Boyang Jason, Li, Xiangyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7472741/ https://www.ncbi.nlm.nih.gov/pubmed/32974183 http://dx.doi.org/10.3389/fonc.2020.01510 |
Ejemplares similares
-
The Mevalonate Pathway, a Metabolic Target in Cancer Therapy
por: Guerra, Borja, et al.
Publicado: (2021) -
Mevalonate Metabolism in Cancer Stemness and Trained Immunity
por: Gruenbacher, Georg, et al.
Publicado: (2018) -
PGC1β Regulates Breast Tumor Growth and Metastasis by SREBP1-Mediated HKDC1 Expression
por: Chen, Xiaoli, et al.
Publicado: (2019) -
Targeting SREBP-1-Mediated Lipogenesis as Potential Strategies for Cancer
por: Zhao, Qiushi, et al.
Publicado: (2022) -
USP28 controls SREBP2 and the mevalonate pathway to drive tumour growth in squamous cancer
por: Maier, Carina R., et al.
Publicado: (2023)